Non–Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data—Methods and Preliminary Results
Top Cited Papers
- 1 August 2012
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 264 (2), 387-396
- https://doi.org/10.1148/radiol.12111607
Abstract
Purpose To identify prognostic imaging biomarkers in non–small cell lung cancer (NSCLC) by means of a radiogenomics strategy that integrates gene expression and medical images in patients for whom survival outcomes are not available by leveraging survival data in public gene expression data sets. Materials and Methods A radiogenomics strategy for associating image features with clusters of coexpressed genes (metagenes) was defined. First, a radiogenomics correlation map is created for a pairwise association between image features and metagenes. Next, predictive models of metagenes are built in terms of image features by using sparse linear regression. Similarly, predictive models of image features are built in terms of metagenes. Finally, the prognostic significance of the predicted image features are evaluated in a public gene expression data set with survival outcomes. This radiogenomics strategy was applied to a cohort of 26 patients with NSCLC for whom gene expression and 180 image features from computed tomography (CT) and positron emission tomography (PET)/CT were available. Results There were 243 statistically significant pairwise correlations between image features and metagenes of NSCLC. Metagenes were predicted in terms of image features with an accuracy of 59%–83%. One hundred fourteen of 180 CT image features and the PET standardized uptake value were predicted in terms of metagenes with an accuracy of 65%–86%. When the predicted image features were mapped to a public gene expression data set with survival outcomes, tumor size, edge shape, and sharpness ranked highest for prognostic significance. Conclusion This radiogenomics strategy for identifying imaging biomarkers may enable a more rapid evaluation of novel imaging modalities, thereby accelerating their translation to personalized medicine. © RSNA, 2012 Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12111607/-/DC1Keywords
This publication has 33 references indexed in Scilit:
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- ArrayExpress update--an archive of microarray and high-throughput sequencing-based functional genomics experimentsNucleic Acids Research, 2010
- HIF-2α deletion promotes Kras-driven lung tumor developmentProceedings of the National Academy of Sciences of the United States of America, 2010
- NCBI GEO: archive for high-throughput functional genomic dataNucleic Acids Research, 2009
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesProceedings of the National Academy of Sciences of the United States of America, 2008
- Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cellsMolecular Cancer, 2007
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular TherapyPLoS Medicine, 2005
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001